
John P. Sheehan
Examiner (ID: 15014)
| Most Active Art Unit | 1101 |
| Art Unit(s) | 1111, 1101, 1742, 1311, 1793, 1102, 1754, 1308, 1736, 3203 |
| Total Applications | 2472 |
| Issued Applications | 1968 |
| Pending Applications | 52 |
| Abandoned Applications | 452 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6101654
[patent_doc_number] => 20110165146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-07
[patent_title] => 'METHODS OF DIAGNOSING ALZHEIMER\'S DISEASE'
[patent_app_type] => utility
[patent_app_number] => 13/005121
[patent_app_country] => US
[patent_app_date] => 2011-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 17369
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20110165146.pdf
[firstpage_image] =>[orig_patent_app_number] => 13005121
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/005121 | METHODS OF DIAGNOSING ALZHEIMER'S DISEASE | Jan 11, 2011 | Abandoned |
Array
(
[id] => 7656775
[patent_doc_number] => 20110306044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-15
[patent_title] => 'DELTA3, FTHMA-070, TANGO85, TANGO77, SPOIL, NEOKINE, TANGO129, AND INTEGRIN ALPHA SUBUNIT PROTEIN AND NUCLEIC ACID MOLECULES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/984939
[patent_app_country] => US
[patent_app_date] => 2011-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 164423
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20110306044.pdf
[firstpage_image] =>[orig_patent_app_number] => 12984939
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/984939 | DELTA3, FTHMA-070, TANGO85, TANGO77, SPOIL, NEOKINE, TANGO129, AND INTEGRIN ALPHA SUBUNIT PROTEIN AND NUCLEIC ACID MOLECULES AND USES THEREOF | Jan 4, 2011 | Abandoned |
Array
(
[id] => 6212960
[patent_doc_number] => 20110136260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-09
[patent_title] => 'SNAPIN AND METHODS FOR REGULATION OF MICROTUBULE ASSEMBLY AND DENDRITE GROWTH AND BRANCHING'
[patent_app_type] => utility
[patent_app_number] => 12/981896
[patent_app_country] => US
[patent_app_date] => 2010-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14610
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20110136260.pdf
[firstpage_image] =>[orig_patent_app_number] => 12981896
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/981896 | Snapin and methods for regulation of microtubule assembly and dendrite growth and branching | Dec 29, 2010 | Issued |
Array
(
[id] => 5984366
[patent_doc_number] => 20110097267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'COMPOSITIONS FOR IMAGING PAIN AND STRESS IN VIVO'
[patent_app_type] => utility
[patent_app_number] => 12/958600
[patent_app_country] => US
[patent_app_date] => 2010-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12347
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20110097267.pdf
[firstpage_image] =>[orig_patent_app_number] => 12958600
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/958600 | COMPOSITIONS FOR IMAGING PAIN AND STRESS IN VIVO | Dec 1, 2010 | Abandoned |
Array
(
[id] => 6081535
[patent_doc_number] => 20110143380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-16
[patent_title] => 'ALZHEIMER\'S DISEASE BIOMARKERS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 12/954259
[patent_app_country] => US
[patent_app_date] => 2010-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 19588
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20110143380.pdf
[firstpage_image] =>[orig_patent_app_number] => 12954259
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/954259 | ALZHEIMER'S DISEASE BIOMARKERS AND METHODS OF USE | Nov 23, 2010 | Abandoned |
Array
(
[id] => 5984594
[patent_doc_number] => 20110097333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'THERAPEUTIC AND DIAGNOSTIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/954201
[patent_app_country] => US
[patent_app_date] => 2010-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 52
[patent_no_of_words] => 36800
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20110097333.pdf
[firstpage_image] =>[orig_patent_app_number] => 12954201
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/954201 | THERAPEUTIC AND DIAGNOSTIC AGENTS | Nov 23, 2010 | Abandoned |
Array
(
[id] => 8697815
[patent_doc_number] => 20130059824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-07
[patent_title] => 'METHODS FOR TREATING MILD COGNITIVE IMPAIRMENT'
[patent_app_type] => utility
[patent_app_number] => 13/511608
[patent_app_country] => US
[patent_app_date] => 2010-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 55062
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13511608
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/511608 | METHODS FOR TREATING MILD COGNITIVE IMPAIRMENT | Nov 22, 2010 | Abandoned |
Array
(
[id] => 11643329
[patent_doc_number] => 09664694
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-30
[patent_title] => 'Neural proteins as biomarkers for nervous system injury and other neural disorders'
[patent_app_type] => utility
[patent_app_number] => 12/950142
[patent_app_country] => US
[patent_app_date] => 2010-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 22
[patent_no_of_words] => 33835
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12950142
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/950142 | Neural proteins as biomarkers for nervous system injury and other neural disorders | Nov 18, 2010 | Issued |
Array
(
[id] => 10870314
[patent_doc_number] => 08895511
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-25
[patent_title] => 'Use of sarcoplasmic CA2+-ATPase type 2 protein for diagnosing and treating learning or mental disorders'
[patent_app_type] => utility
[patent_app_number] => 13/511388
[patent_app_country] => US
[patent_app_date] => 2010-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12102
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13511388
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/511388 | Use of sarcoplasmic CA2+-ATPase type 2 protein for diagnosing and treating learning or mental disorders | Nov 15, 2010 | Issued |
Array
(
[id] => 6054582
[patent_doc_number] => 20110110942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-12
[patent_title] => 'METHOD OF PROMOTING DENDRITIC SPINE DENSITY'
[patent_app_type] => utility
[patent_app_number] => 12/944869
[patent_app_country] => US
[patent_app_date] => 2010-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 27081
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20110110942.pdf
[firstpage_image] =>[orig_patent_app_number] => 12944869
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/944869 | METHOD OF PROMOTING DENDRITIC SPINE DENSITY | Nov 11, 2010 | Abandoned |
Array
(
[id] => 5944104
[patent_doc_number] => 20110104724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'BIOMARKERS OF MILD COGNITIVE IMPAIRMENT AND ALZHEIMER\'S DISEASE'
[patent_app_type] => utility
[patent_app_number] => 12/941721
[patent_app_country] => US
[patent_app_date] => 2010-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10806
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20110104724.pdf
[firstpage_image] =>[orig_patent_app_number] => 12941721
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/941721 | BIOMARKERS OF MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE | Nov 7, 2010 | Abandoned |
Array
(
[id] => 8317301
[patent_doc_number] => 08232076
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-07-31
[patent_title] => 'Neurogenin'
[patent_app_type] => utility
[patent_app_number] => 12/941936
[patent_app_country] => US
[patent_app_date] => 2010-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 19800
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12941936
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/941936 | Neurogenin | Nov 7, 2010 | Issued |
Array
(
[id] => 8465675
[patent_doc_number] => 20120270844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-25
[patent_title] => 'METHODS FOR TREATING ALZHEIMER\'S DISEASE'
[patent_app_type] => utility
[patent_app_number] => 13/500293
[patent_app_country] => US
[patent_app_date] => 2010-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 56101
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 57
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13500293
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/500293 | METHODS FOR TREATING ALZHEIMER'S DISEASE | Oct 7, 2010 | Abandoned |
Array
(
[id] => 6102582
[patent_doc_number] => 20110166075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-07
[patent_title] => 'METHOD OF TREATING DEGENERATIVE DISORDERS OF THE NERVOUS SYSTEM BY ADMINISTRATION OF FIBRINOGEN FRAGMENT'
[patent_app_type] => utility
[patent_app_number] => 12/896410
[patent_app_country] => US
[patent_app_date] => 2010-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 47
[patent_no_of_words] => 18671
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20110166075.pdf
[firstpage_image] =>[orig_patent_app_number] => 12896410
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/896410 | METHOD OF TREATING DEGENERATIVE DISORDERS OF THE NERVOUS SYSTEM BY ADMINISTRATION OF FIBRINOGEN FRAGMENT | Sep 30, 2010 | Abandoned |
Array
(
[id] => 6162946
[patent_doc_number] => 20110160138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-30
[patent_title] => 'COMPOSITION FOR IMPROVING BRAIN FUNCTION AND METHOD FOR IMPROVING BRAIN FUNCTION'
[patent_app_type] => utility
[patent_app_number] => 12/889652
[patent_app_country] => US
[patent_app_date] => 2010-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5425
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20110160138.pdf
[firstpage_image] =>[orig_patent_app_number] => 12889652
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/889652 | Composition for improving brain function and method for improving brain function | Sep 23, 2010 | Issued |
Array
(
[id] => 6162947
[patent_doc_number] => 20110160139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-30
[patent_title] => 'COMPOSITION FOR IMPROVING BRAIN FUNCTION AND METHOD FOR IMPROVING BRAIN FUNCTION'
[patent_app_type] => utility
[patent_app_number] => 12/889853
[patent_app_country] => US
[patent_app_date] => 2010-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4224
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20110160139.pdf
[firstpage_image] =>[orig_patent_app_number] => 12889853
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/889853 | Composition for improving brain function and method for improving brain function | Sep 23, 2010 | Issued |
Array
(
[id] => 6162964
[patent_doc_number] => 20110160140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-30
[patent_title] => 'COMPOSITION FOR IMPROVING BRAIN FUNCTION AND METHOD FOR IMPROVING BRAIN FUNCTION'
[patent_app_type] => utility
[patent_app_number] => 12/890174
[patent_app_country] => US
[patent_app_date] => 2010-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4025
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20110160140.pdf
[firstpage_image] =>[orig_patent_app_number] => 12890174
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/890174 | Composition for improving brain function and method for improving brain function | Sep 23, 2010 | Issued |
Array
(
[id] => 8571734
[patent_doc_number] => 08338379
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-25
[patent_title] => 'Monoclonal antibody and use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/888661
[patent_app_country] => US
[patent_app_date] => 2010-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8237
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12888661
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/888661 | Monoclonal antibody and use thereof | Sep 22, 2010 | Issued |
Array
(
[id] => 5937357
[patent_doc_number] => 20110212896
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-01
[patent_title] => 'PEPTIDES FOR THE TREATMENT OF OXIDATIVE STRESS RELATED DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 13/127494
[patent_app_country] => US
[patent_app_date] => 2010-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 14085
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20110212896.pdf
[firstpage_image] =>[orig_patent_app_number] => 13127494
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/127494 | Peptides for the treatment of oxidative stress related disorders | Sep 15, 2010 | Issued |
Array
(
[id] => 5959523
[patent_doc_number] => 20110183910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-07-28
[patent_title] => 'BIGLYCAN AND RELATED THERAPEUTICS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 12/881891
[patent_app_country] => US
[patent_app_date] => 2010-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 36194
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20110183910.pdf
[firstpage_image] =>[orig_patent_app_number] => 12881891
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/881891 | Biglycan and related therapeutics and methods of use | Sep 13, 2010 | Issued |